Your browser doesn't support javascript.
loading
Discovery of Novel Digital Biomarkers for Type 2 Diabetic Nephropathy Classification via Integration of Urinary Proteomics and Pathology.
Lucarelli, Nicholas; Yun, Donghwan; Han, Dohyun; Ginley, Brandon; Moon, Kyung Chul; Rosenberg, Avi Z; Tomaszewski, John E; Zee, Jarcy; Jen, Kuang-Yu; Han, Seung Seok; Sarder, Pinaki.
Affiliation
  • Lucarelli N; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, USA.
  • Yun D; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Han D; Proteomics Core Facility, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
  • Ginley B; The Janssen Pharmaceutical Companies of Johnson & Johnson, Raritan NJ, USA.
  • Moon KC; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Rosenberg AZ; Department of Pathology, Johns Hopkins University, Baltimore, MD, USA.
  • Tomaszewski JE; Department of Pathology and Anatomical Sciences, University at Buffalo - The State University of New York.
  • Zee J; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania and Children's Hospital of Philadelphia, PA, USA.
  • Jen KY; Department of Pathology and Laboratory Medicine, University of California, Davis Medical Center, CA, USA.
  • Han SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Sarder P; Department of Medicine-Quantitative Health, University of Florida College of Medicine, Gainesville, FL, USA.
medRxiv ; 2023 May 03.
Article in En | MEDLINE | ID: mdl-37205413
ABSTRACT

Background:

The heterogeneous phenotype of diabetic nephropathy (DN) from type 2 diabetes complicates appropriate treatment approaches and outcome prediction. Kidney histology helps diagnose DN and predict its outcomes, and an artificial intelligence (AI)-based approach will maximize clinical utility of histopathological evaluation. Herein, we addressed whether AI-based integration of urine proteomics and image features improves DN classification and its outcome prediction, altogether augmenting and advancing pathology practice.

Methods:

We studied whole slide images (WSIs) of periodic acid-Schiff-stained kidney biopsies from 56 DN patients with associated urinary proteomics data. We identified urinary proteins differentially expressed in patients who developed end-stage kidney disease (ESKD) within two years of biopsy. Extending our previously published human-AI-loop pipeline, six renal sub-compartments were computationally segmented from each WSI. Hand-engineered image features for glomeruli and tubules, and urinary protein measurements, were used as inputs to deep-learning frameworks to predict ESKD outcome. Differential expression was correlated with digital image features using the Spearman rank sum coefficient.

Results:

A total of 45 urinary proteins were differentially detected in progressors, which was most predictive of ESKD (AUC=0.95), while tubular and glomerular features were less predictive (AUC=0.71 and AUC=0.63, respectively). Accordingly, a correlation map between canonical cell-type proteins, such as epidermal growth factor and secreted phosphoprotein 1, and AI-based image features was obtained, which supports previous pathobiological results.

Conclusions:

Computational method-based integration of urinary and image biomarkers may improve the pathophysiological understanding of DN progression as well as carry clinical implications in histopathological evaluation.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: MedRxiv Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: MedRxiv Year: 2023 Document type: Article Affiliation country: